1. Potential New Cancer Immunotherapy: Anti-CD47-SIRPα Antibodies

    Quansheng Lu et al, 2020, OncoTargets and Therapy CrossRef
  2. EZH2‐mediated SLC7A11 upregulation via miR‐125b‐5p represses ferroptosis of TSCC
    Yue Yu et al, 2023, Oral Diseases CrossRef
  3. Plumbagin has an inhibitory effect on the growth of TSCC PDX model and it enhances the anticancer efficacy of cisplatin
    Yuqi Xin et al, 2023, Aging CrossRef
  4. Targeting CD47 Inhibits Tumor Development and Increases Phagocytosis in Oral Squamous Cell Carcinoma
    Xiao-Jing Ye et al, 2021, Anti-Cancer Agents in Medicinal Chemistry CrossRef
  5. CD47 Expression in Non-Melanoma Skin Cancers and Its Clinicopathological Implications
    Seongsik Bang et al, 2022, Diagnostics CrossRef
  6. Crosstalk between cancer stem cells and the tumor microenvironment drives progression of premalignant oral epithelium
    Peter J. Polverini et al, 2023, Frontiers in Oral Health CrossRef
  7. Evaluation of CD47 Expression in Solid Pancreatic Tumors Diagnosed with Endosonography Guided Fine Needle Aspiration Biopsy
    Nurcan Ünver et al, 2022, Hamidiye Medical Journal CrossRef